Fuller SA - Search Results

1

Fahim RE, Kessler PD, Fuller SA, Kalnik MW. Fahim RE, et al. Among authors: fuller sa. CNS Neurol Disord Drug Targets. 2011 Dec;10(8):905-15. doi: 10.2174/187152711799219343. CNS Neurol Disord Drug Targets. 2011. PMID: 22229310 Review.

2

Attenuating nicotine's effects with high affinity human anti-nicotine monoclonal antibodies.

Raleigh MD, Beltraminelli N, Fallot S, LeSage MG, Saykao A, Pentel PR, Fuller S, Thisted T, Biesova Z, Horrigan S, Sampey D, Zhou B, Kalnik MW. Raleigh MD, et al. PLoS One. 2021 Jul 30;16(7):e0254247. doi: 10.1371/journal.pone.0254247. eCollection 2021. PLoS One. 2021. PMID: 34329335 Free PMC article.

3

Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin.

Drulak MW, Malinoski FJ, Fuller SA, Stewart SS, Hoskin S, Duliege AM, Sekulovich R, Burke R, Winston S. Drulak MW, et al. Among authors: fuller sa. Viral Immunol. 2000;13(1):49-56. doi: 10.1089/vim.2000.13.49. Viral Immunol. 2000. PMID: 10733168 Clinical Trial.

4

PAN-811 prevents chemotherapy-induced cognitive impairment and preserves neurogenesis in the hippocampus of adult rats.

Jiang ZG, Winocur G, Wojtowicz JM, Shevtsova O, Fuller S, Ghanbari HA. Jiang ZG, et al. PLoS One. 2018 Jan 25;13(1):e0191866. doi: 10.1371/journal.pone.0191866. eCollection 2018. PLoS One. 2018. PMID: 29370277 Free PMC article.

5

Purification of monoclonal antibodies.

Fuller SA, Takahashi M, Hurrell JG. Fuller SA, et al. Curr Protoc Mol Biol. 2001 May;Chapter 11:Unit11.11. doi: 10.1002/0471142727.mb1111s37. Curr Protoc Mol Biol. 2001. PMID: 18265069

6

Enzyme-linked immunosorbent assays (ELISA).

Hornbeck P, Winston SE, Fuller SA. Hornbeck P, et al. Among authors: fuller sa. Curr Protoc Mol Biol. 2001 May;Chapter 11:Unit11.2. doi: 10.1002/0471142727.mb1102s15. Curr Protoc Mol Biol. 2001. PMID: 18265074

7

Enhancement of hybridoma production by medium supplemented with murine ascitic fluid.

Stewart SS, Fuller SA. Stewart SS, et al. Among authors: fuller sa. J Immunol Methods. 1989 Sep 29;123(1):45-53. doi: 10.1016/0022-1759(89)90028-8. J Immunol Methods. 1989. PMID: 2794529

8

Design and production of bispecific monoclonal antibodies by hybrid hybridomas for use in immunoassay.

Takahashi M, Fuller SA, Winston S. Takahashi M, et al. Among authors: fuller sa. Methods Enzymol. 1991;203:312-27. doi: 10.1016/0076-6879(91)03018-c. Methods Enzymol. 1991. PMID: 1762562 No abstract available.

9

Immunoblotting and immunodetection.

Gallagher S, Winston SE, Fuller SA, Hurrell JGR. Gallagher S, et al. Among authors: fuller sa. Curr Protoc Immunol. 2001 May;Chapter 8:8.10.1-8.10.21. doi: 10.1002/0471142735.im0810s26. Curr Protoc Immunol. 2001. PMID: 18432850

10

PAN-811 Blocks Chemotherapy Drug-Induced In Vitro Neurotoxicity, While Not Affecting Suppression of Cancer Cell Growth.

Jiang ZG, Fuller SA, Ghanbari HA. Jiang ZG, et al. Among authors: fuller sa. Oxid Med Cell Longev. 2016;2016:9392404. doi: 10.1155/2016/9392404. Epub 2015 Nov 10. Oxid Med Cell Longev. 2016. PMID: 26640619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

77 results

Search Page